Dopamine/serotonin receptor ligands. Part 15: Oxygenation of the benz-indolo-azecine LE 300 leads to novel subnanomolar dopamine D1/D5 antagonists (original ) (raw )Dopamine/Serotonin Receptor Ligands. Part IV [1]: Synthesis and Pharmacology of Novel 3-Benzazecines and 3-Benzazonines as Potential 5-HT2A and Dopamine Receptor Ligands
Hussein El-subbagh
Archiv der Pharmazie, 2002
View PDFchevron_right
Dopamine/Serotonin Receptor Ligands, Part III [1]: Synthesis and Biological Activities of 7, 7′—Alkylene-bis-6, 7, 8, 9, 14, 15-hexahydro-5H-benz[d]indolo[2, 3-g]azecines — Application of the Bivalent Ligand Approach to a Novel Type of Dopamine Receptor Antagonist
Ashraf Abadi
Archiv Der Pharmazie, 2002
View PDFchevron_right
Dopamine/Serotonin Receptor Ligands. 12 1 : SAR Studies on Hexahydro-dibenz[ d , g ]azecines Lead to 4-Chloro-7-methyl-5,6,7,8,9,14-hexahydrodibenz[ d,g ]azecin-3-ol, the First Picomolar D 5 -Selective Dopamine-Receptor Antagonist
Christoph Enzensperger
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
Dopamine/Serotonin Receptor Ligands. 10: 1 SAR Studies on Azecine-type Dopamine Receptor Ligands by Functional Screening at Human Cloned D 1 , D 2L , and D 5 Receptors with a Microplate Reader Based Calcium Assay Lead to a Novel Potent D 1 /D 5 Selective Antagonist
Sherif Rostom , Matthias Kassack , Hussein El-subbagh
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
(.+-.)-(Aminoalkyl)benzazepine Analogs: Novel Dopamine D1 Receptor Antagonists
Jeffrey Witkin
Journal of Medicinal Chemistry, 1995
View PDFchevron_right
Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol
R. Chipkin , Donald Hou
Journal of medicinal chemistry, 1989
View PDFchevron_right
Dopamine/serotonin receptor ligands. Part 17: A cross-target SAR approach: Affinities of azecine-styled ligands for 5-HT2A versus D1 and D2 receptors
Christoph Enzensperger
Bioorganic & Medicinal Chemistry Letters, 2008
View PDFchevron_right
Novel 2,3,4,5-tetrahydro-1H-3-benzazepines with high affinity and selectivity for the dopamine D3 receptor
martyn wood
Bioorganic & Medicinal Chemistry Letters, 2000
View PDFchevron_right
(±)-3-[4‘-( N , N -Dimethylamino)cinnamyl]benzazepine Analogs: Novel Dopamine D 1 Receptor Antagonists †
Jeffrey Witkin
Journal of Medicinal Chemistry, 1996
View PDFchevron_right
Synthesis and characterization of selective dopamine D2 receptor antagonists. 2. Azaindole, benzofuran, and benzothiophene analogs of L-741,626
Robert Mach , Jinbin Xu
Bioorganic & Medicinal Chemistry, 2010
View PDFchevron_right
Dopamine receptor agonists: 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol and a series of related 3-benzazepines
Robert Demarinis
Journal of Medicinal Chemistry, 1986
View PDFchevron_right
Chiral Indolo[3,2- f ][3]benzazecine-Type Dopamine Receptor Antagonists: Synthesis and Activity of Racemic and Enantiopure Derivatives
Christoph Enzensperger , Hussein El-subbagh
Journal of Medicinal Chemistry, 2011
View PDFchevron_right
Design, synthesis, and discovery of 5-piperazinyl-1,2,6,7-tetrahydro-5H-azepino[3,2,1-hi]indol-4-one derivatives: A novel series of mixed dopamine D2/D4 receptor antagonist
Xiaoyan Zhang
Bioorganic & Medicinal Chemistry Letters, 2003
View PDFchevron_right
The synthesis, and dopamine D2 and serotonin 5-HT3 receptor affinity of 3-aza analogues (pyridyl) of 4-amino-5-chloro-2-methoxybenzamides
Frank King
Bioorganic & Medicinal Chemistry Letters, 1995
View PDFchevron_right
Structure−Activity Relationships for a Novel Series of Dopamine D2-like Receptor Ligands Based on N-Substituted 3-Aryl-8-azabicyclo[3.2.1]octan-3-ol
Jonathan Katz
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
New generation dopaminergic agents 4. Exploiting the 2-methyl chroman scaffold. Synthesis and evaluation of two novel series of 2-(aminomethyl)-3,4,7,9-tetrahydro-2H-pyrano[2,3-e]indole and indol-8-one derivatives
Georgia McGaughey
Tetrahedron, 1998
View PDFchevron_right
Resolved 6,7,8,9-tetrahydro-N,N-dimethyl-3H-benz[e]indol-8-amine: central dopamine and serotonin receptor stimulating properties
Kjell Svensson
Journal of Medicinal Chemistry, 1989
View PDFchevron_right
(.+-.)-3-Allyl-7-halo-8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines as selective high affinity D1 dopamine receptor antagonists: synthesis and structure-activity relationship
Mai Tran
Journal of Medicinal Chemistry, 1992
View PDFchevron_right
Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands
Bassem S H A B A N Sadek
Frontiers in Chemistry
View PDFchevron_right
Further Definition of the D1 Dopamine Receptor Pharmacophore: Synthesis of trans-6,6a,7,8,9,13b-Hexahydro-5H-benzo[d]naphth[2,1-b]azepines as Rigid Analogues of β-Phenyldopamine
Val Watts
Journal of Medicinal Chemistry, 1997
View PDFchevron_right
Azaindole derivatives with high affinity for the dopamine D4 receptor: Synthesis, ligand binding studies and comparison of molecular electrostatic potential maps
Harald Hübner
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
(.+-.)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine, a new high affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship
John Neumeyer
Journal of Medicinal Chemistry, 1991
View PDFchevron_right
Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands
Ferran Sanz
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Dopamine receptor binding properties of some 2,3,4,5-tetrahydro-1H-3-benzazepine-7-ols with non-aromatic substituents in the 5-position
Vicki COFFIN
Bioorganic & Medicinal Chemistry Letters, 1992
View PDFchevron_right
Synthesis and in vitro pharmacological evaluation of indolyl carboxylic amide analogues as D3 dopamine receptor selective ligands
Robert Mach
MedChemComm, 2013
View PDFchevron_right
Design and discovery of 1,3-benzodiazepines as novel dopamine antagonists
Brian McKittrick
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Synthesis and dopamine receptor binding of some pyrazolo [3', 4': 6, 7] azepino [5, 4, 3-cd] indoles
Kayed Abu-Safieh
2003
View PDFchevron_right
Dopamine D 3 Receptor Antagonists. 1. Synthesis and Structure−Activity Relationships of 5,6-Dimethoxy- N -alkyl- and N -Alkylaryl-Substituted 2-Aminoindans
Kjell Svensson
Journal of Medicinal Chemistry, 2001
View PDFchevron_right
2-{4-[ω-[4-(2-Methoxyphenyl)-1-piperazinyl]alkoxy]phenyl}-2H -benzotr iazoles and their N-Oxides as Ligands for some 5-Hydroxytryptamine, Dopamine and Adrenergic Receptor Subtypes
Fabio Sparatore
Pharmacy and Pharmacology Communications, 2000
View PDFchevron_right
trans-2,6-, 3,6- and 4,6-Diaza-5,6,6a,7,8,12b-hexahydrobenzo[C]phenanthrene-10,11-diols as dopamine agonists
Yu-Gui Gu
Bioorganic & Medicinal Chemistry Letters, 1999
View PDFchevron_right
2-{4-[ω-[4-(2-Methoxyphenyl)-1-piperazinyl]alkoxy]phenyl}-2 H -benzotr iazoles and their N-Oxides as Ligands for some 5-Hydroxytryptamine, Dopamine and Adrenergic Receptor Subtypes
Fabio Sparatore
Pharmacy and Pharmacology Communications, 2000
View PDFchevron_right
Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity
Diana Canseco
2003
View PDFchevron_right